fda compounding semaglutide news november 2025 Beyond the Headlines: Warning Letters to GLP-1 Compounders US judge upholds FDA's removal

Cardiac chest pain typically presents as pressure, tightness, or squeezing in the central chest, often radiating to the left arm, jaw, neck, or back

coli 71

Rhynchophylline attenuates LPS-induced pro-inflammatory responses through down-regulation of MAPK/NF-B signaling pathways in primary microglia

Retrieved from DailyMed: Wittmer Rejuvenation Clinic

Key Takeaways Retatrutide activates GLP-1R, GIPR, and GCGR simultaneously, making it structurally distinct from both semaglutide (GLP-1 only) and tirzepatide (GLP-1 and GIP only)

Alexander Goldowsky, a gastroenterologist at Harvard-affiliated Beth Israel Deaconess Medical Center